Infectious Disease Rapid Diagnostic Testing market

Infectious Disease Rapid Diagnostic Testing Market, Global Outlook and Forecast 2022-2028

  • 07 April 2022
  • Life Sciences
  • 100 Pages
  • Report code : PMR-6980593

  • 4.7 (158)

Infectious Disease Rapid Diagnostic Testing Market

Download FREE Report Sample

  Download Free sample

Infectious Disease Rapid Diagnostic Testing Market contains market size and forecasts of Infectious Disease Rapid Diagnostic Testing in Global, including the following market information:

Global Infectious Disease Rapid Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Infectious Disease Rapid Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Assays Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Infectious Disease Rapid Diagnostic Testing include Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc. and Mesa Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Infectious Disease Rapid Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Infectious Disease Rapid Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)

Assays

Platforms

Global Infectious Disease Rapid Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)

Respiratory Infection

Gastro-Intestinal Infection

Center Nervous System Infection

Hospital Acquired Infection

Sexually Transmitted Infections

Others

Global Infectious Disease Rapid Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Infectious Disease Rapid Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Infectious Disease Rapid Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Infectious Disease Rapid Diagnostic Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

Roche Ltd

Danaher Corporation

Luminex Corporation

BGI Group

bioMerieux S.A.

DiaSorin S.p.A

Hologic, Inc.

Mesa Biotech

Quidel Corporation

Thermo Fisher Scientific Inc.

GenMark Diagnostics

CTK Biotech

Becton Dickinson

Cellex Inc.

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Infectious Disease Rapid Diagnostic Testing Market

Leave This Empty: